MA27313A1 - Pates veterinaires homogenes orales anthelminthiques. - Google Patents
Pates veterinaires homogenes orales anthelminthiques.Info
- Publication number
- MA27313A1 MA27313A1 MA28026A MA28026A MA27313A1 MA 27313 A1 MA27313 A1 MA 27313A1 MA 28026 A MA28026 A MA 28026A MA 28026 A MA28026 A MA 28026A MA 27313 A1 MA27313 A1 MA 27313A1
- Authority
- MA
- Morocco
- Prior art keywords
- anthelmintic
- ingenious
- formulations
- oral
- animals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Cette invention fournit les p??tes homogènes orales pour le traitement, le contrôle et la prévention des infections endo et ectoparasites chez les animaux à sang chaud, comme les chevaux, les animaux domestiques et les oiseaux ainsi que pour le procédé de préparation de ces formulations. Les p??tes anthelminthiques orales ingénieuses comprennent un premier agent anthelminthique comme le praziquantel et/ou pyrantel, et comme un second agent, au moins un corps composé anthélminthique macrolide, comme un avermectine ou milbemycine, dissous dans un dissolvant qui fait dissoudre le premier corps composé anthelminthique et le composé anthelminthique macrolide et un agent épaississant. Les p??tes vétérinaires orales ingénieuses offrent un traitement plus effectif des infections parasitiques chez les animaux non humains puisque les ingrédients actifs ne s'interfèrent pas entre eux, et donc développent la bio disponibilité chez l'animal, en gardant les bénéfices de se distribuer toujours comme une p??te. En outre, les formulations ingénieuses offrent une formulation qui montre une bonne stabilité chimique et physique sur la durée de vie en stock du produit. Ainsi, les formulations vétérinaires orales de l'invention montrent les bénéfices des deux p??tes comme les deux solution et formulation. En outre, l'invention présente offre un procédé de fabrication des formulations ingénieuses ainsi qu'une méthode pour le développement de la bio disponibilité du premier agent anthelminthique et le composé anthélementique macrolide chez l'animal ou l'oiseau à sang chaud. Ces contenus ou autres sont révélés ou sont une forme claire et comprise par la description détaillée suivante.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/177,822 US7001889B2 (en) | 2002-06-21 | 2002-06-21 | Anthelmintic oral homogeneous veterinary pastes |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27313A1 true MA27313A1 (fr) | 2005-05-02 |
Family
ID=29734505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA28026A MA27313A1 (fr) | 2002-06-21 | 2004-12-30 | Pates veterinaires homogenes orales anthelminthiques. |
Country Status (20)
Country | Link |
---|---|
US (2) | US7001889B2 (fr) |
EP (1) | EP1534072B1 (fr) |
JP (1) | JP4342440B2 (fr) |
AR (1) | AR039722A1 (fr) |
AT (1) | ATE390123T1 (fr) |
AU (1) | AU2009200336B2 (fr) |
BR (1) | BR0312141A (fr) |
CA (1) | CA2490309C (fr) |
CY (1) | CY1108533T1 (fr) |
DE (1) | DE60319996T2 (fr) |
DK (1) | DK1534072T3 (fr) |
ES (1) | ES2306879T3 (fr) |
MA (1) | MA27313A1 (fr) |
MX (1) | MXPA05000172A (fr) |
NZ (2) | NZ555185A (fr) |
PT (1) | PT1534072E (fr) |
SI (1) | SI1534072T1 (fr) |
TN (1) | TNSN04258A1 (fr) |
WO (1) | WO2004000034A2 (fr) |
ZA (1) | ZA200410250B (fr) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893652B2 (en) | 2001-08-27 | 2005-05-17 | Wyeth | Endoparasiticidal gel composition |
US20060205681A1 (en) * | 2002-06-21 | 2006-09-14 | Maryam Moaddeb | Homogenous paste formulations |
US7001889B2 (en) * | 2002-06-21 | 2006-02-21 | Merial Limited | Anthelmintic oral homogeneous veterinary pastes |
US6991801B2 (en) * | 2003-04-04 | 2006-01-31 | Merial Limited | Topical anthelmintic veterinary formulations |
CN1894581B (zh) * | 2003-07-09 | 2012-02-01 | 生命技术公司 | 检测蛋白-蛋白相互作用的方法 |
US7396819B2 (en) * | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
US7671034B2 (en) * | 2003-12-19 | 2010-03-02 | Merial Limited | Stabilized formulation of ivermectin feed premix with an extended shelf life |
EP1566173B1 (fr) * | 2004-02-20 | 2006-08-16 | Mattern, Udo | Composition pharmaceutique orale et procédé de preparation |
WO2005094210A2 (fr) * | 2004-03-12 | 2005-10-13 | The Hartz Mountain Corporation | Formulations anthelmintiques a actions multiples |
EP1796692B1 (fr) * | 2004-09-09 | 2012-05-02 | Warburton Technology Limited | Oligoelements |
DE102005011779A1 (de) * | 2005-03-11 | 2006-09-14 | Bayer Healthcare Ag | Endoparasitizide Mittel |
US20080027011A1 (en) * | 2005-12-20 | 2008-01-31 | Hassan Nached | Homogeneous paste and gel formulations |
AU2006203347C1 (en) * | 2006-05-15 | 2009-11-05 | Wyeth | Stabilised formulation |
BRPI0714194A2 (pt) | 2006-07-05 | 2012-12-25 | Aventis Agriculture | compostos derivados de 1-aril-5-alquilpirazol, processos para fazÊ-los e mÉtodos para seus usos |
NZ550279A (en) * | 2006-09-29 | 2008-01-31 | Bomac Research Ltd | Medicament |
PT3428148T (pt) | 2007-05-15 | 2020-10-13 | Aventis Agriculture | Compostos de ariloazol-2-il-cianoetilamino, método de fabrico e seu método de utilização |
ES2716474T3 (es) | 2007-10-26 | 2019-06-12 | Avivagen Inc | Composiciones y métodos para mejorar la respuesta inmunitaria |
JP5319691B2 (ja) * | 2007-11-15 | 2013-10-16 | ノバルティス アーゲー | プラジカンテル、マクロライドラクトン、シクロデキストリンおよび粘稠化剤を含む駆虫ペースト |
AU2009271299B2 (en) * | 2008-06-24 | 2014-09-11 | Boehringer Ingelheim Animal Health USA Inc. | Anthelminthic formulations |
CA2733698A1 (fr) * | 2008-08-20 | 2010-02-25 | Futurefuel Chemical Company | Procede de preparation de glycerol formal |
MX2009001235A (es) * | 2008-09-19 | 2010-04-29 | Agrovet Market S A | Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina. |
ES2729854T3 (es) | 2008-11-14 | 2019-11-06 | Merial Inc | Compuestos de ariloazol-2-ilcianoetilamino parasiticidas enriquecidos enantioméricamente |
NZ592865A (en) | 2008-11-19 | 2013-08-30 | Merial Ltd | Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof |
CN102282154B (zh) | 2008-12-04 | 2015-07-01 | 梅瑞尔公司 | 二聚的阿佛菌素和米尔倍霉素衍生物 |
US10456369B2 (en) | 2009-04-30 | 2019-10-29 | Avivagen Inc. | Methods and compositions for improving the health of animals |
TW201041508A (en) * | 2009-04-30 | 2010-12-01 | Dow Agrosciences Llc | Pesticide compositions exhibiting enhanced activity |
MX2012001170A (es) | 2009-07-30 | 2012-07-20 | Merial Ltd | Compuestos de 4-amino-tieno [2,3-d]pirimidina insecticidas y metodos para su uso. |
US8846569B2 (en) | 2009-12-04 | 2014-09-30 | Merial Limited | Pesticidal bis-organosulfur compounds |
ES2894036T3 (es) | 2009-12-17 | 2022-02-11 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos de dihidroazol antiparasitarios y composiciones que los comprenden |
BR112012014933B1 (pt) | 2009-12-17 | 2020-10-27 | Merial, Inc. | composições que compreendem compostos lactonas macrocíclicas e spirodioxepinoindóis |
UA108641C2 (uk) | 2010-04-02 | 2015-05-25 | Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування | |
DK2640728T3 (en) | 2010-11-16 | 2016-11-28 | Merial Inc | NEW MONENSINDERIVATER FOR TREATMENT AND PREVENTION OF protozoal INFECTIONS |
US20120329832A1 (en) | 2011-06-27 | 2012-12-27 | Jean Delaveau | Novel Insect-Repellent Coumarin Derivatives, Syntheses, and Methods of Use |
ES2618813T3 (es) | 2011-06-27 | 2017-06-22 | Merial, Inc. | Compuestos y composiciones de éter amido-piridílico y uso contra los parásitos |
US9173404B2 (en) | 2011-11-17 | 2015-11-03 | Merial, Inc. | Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof |
EP2594258B1 (fr) | 2011-11-18 | 2020-03-18 | Veterinärmedizinische Universität Wien | Gel oral comprenant du praziquantel |
PL2785719T3 (pl) | 2011-12-02 | 2018-03-30 | Merial, Inc. | Długodziałające wstrzykiwalne postaci moksydektyny i nowe postaci krystaliczne moksydektyny |
AU2013201479C1 (en) * | 2012-03-13 | 2017-11-09 | Elanco New Zealand | Long Acting Compositions |
DK2922845T3 (en) | 2012-11-20 | 2018-09-24 | Merial Inc | ANTHELMINTIC COMPOUNDS AND COMPOSITIONS AND PROCEDURES FOR USE THEREOF |
JP6499970B2 (ja) * | 2013-10-30 | 2019-04-10 | 大蔵製薬株式会社 | 服用し易いゼリー状医薬組成物 |
ES2905848T3 (es) | 2013-11-01 | 2022-04-12 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos de isoxazolina antiparasitarios y plaguicidas |
US10045979B2 (en) | 2014-05-19 | 2018-08-14 | Merial Inc. | Anthelmintic compounds |
WO2016054373A1 (fr) * | 2014-10-01 | 2016-04-07 | Merial Inc. | Essai de dissolution d'ingrédients pharmaceutiques actifs hydrophobes comme les avermectines avec ou sans pyrantel |
DK3298027T3 (da) | 2015-05-20 | 2021-08-09 | Boehringer Ingelheim Animal Health Usa Inc | Anthelmintiske depsipeptidforbindelser |
UY37137A (es) | 2016-02-24 | 2017-09-29 | Merial Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
AU2017310506B2 (en) | 2016-08-11 | 2019-11-21 | Dmk Pharmaceuticals Corporation | Drug compositions |
WO2018039508A1 (fr) | 2016-08-25 | 2018-03-01 | Merial, Inc. | Procédé de réduction d'effets indésirables dans des traitements antiparasitaires |
US10653144B2 (en) | 2016-10-14 | 2020-05-19 | Boehringer Ingelheim Animal Health USA Inc. | Pesticidal and parasiticidal vinyl isoxazoline compounds |
BR112019009977A2 (pt) | 2016-11-16 | 2019-08-27 | Boehringer Ingelheim Animal Health Usa Inc | compostos depsipeptídicos anti-helmínticos |
WO2019036407A1 (fr) | 2017-08-14 | 2019-02-21 | Merial, Inc. | Composés de pyrazole-isoxazoline à activité pesticide et parasiticide |
RU2681214C1 (ru) * | 2017-10-12 | 2019-03-05 | Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук | Способ получения средства для лечения однокопытных животных при паразитозах |
US11564910B2 (en) | 2017-12-08 | 2023-01-31 | Adamis Pharmaceuticals Corporation | Drug compositions |
WO2019157241A1 (fr) | 2018-02-08 | 2019-08-15 | Boehringer Ingelheim Animal Health USA Inc. | Compositions parasiticides comprenant de l'éprinomectine et du praziquantel, procédés et utilisations associés |
CN112996788B (zh) | 2018-07-09 | 2024-07-16 | 勃林格殷格翰动物保健美国公司 | 驱蠕虫的杂环化合物 |
EP3883648A1 (fr) | 2018-11-20 | 2021-09-29 | Boehringer Ingelheim Animal Health USA Inc. | Composé indazolylcyanoéthylamino, compositions associées, procédé de fabrication et procédés d'utilisation de celui-ci |
WO2020191091A1 (fr) | 2019-03-19 | 2020-09-24 | Boehringer Ingelheim Animal Health USA Inc. | Composés d'aza-benzothiophène et d'aza-benzofurane anthelminthiques |
WO2021242581A1 (fr) | 2020-05-29 | 2021-12-02 | Boehringer Ingelheim Animal Health USA Inc. | Composés hétérocycliques anthelminthiques |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3502661A (en) * | 1967-02-14 | 1970-03-24 | Pfizer & Co C | Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl) pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines |
US4001441A (en) * | 1970-12-21 | 1977-01-04 | The Procter & Gamble Company | Meat analog |
US3950360A (en) * | 1972-06-08 | 1976-04-13 | Sankyo Company Limited | Antibiotic substances |
US4196291A (en) * | 1973-12-17 | 1980-04-01 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof |
US4032655A (en) * | 1974-05-15 | 1977-06-28 | Bayer Aktiengesellschaft | Phenylguanidines useful as anthelmintic agents |
IN142490B (fr) * | 1974-05-15 | 1977-07-16 | Bayer Ag | |
SE434277B (sv) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
US5089490A (en) * | 1977-04-02 | 1992-02-18 | Hoechst Aktiengesellschaft | Cephem derivatives |
IL54474A (en) * | 1977-04-12 | 1982-04-30 | Ciba Geigy Ag | Benzimidazole derivatives,their preparation and anthelmintic compositions containing them |
PH15982A (en) | 1977-10-03 | 1983-05-18 | Merck & Co Inc | Selective hydrogenation producta of c-076 compounds and derivatives thereof |
NZ188459A (en) | 1977-10-03 | 1982-09-07 | Merck & Co Inc | Derivatives of c-076 compounds and pesticidal compositions |
US4199569A (en) * | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
US4200581A (en) * | 1978-08-04 | 1980-04-29 | Merck & Co., Inc. | Alkyl derivatives of C-076 compounds |
EP0021758B1 (fr) | 1979-06-27 | 1984-04-04 | Beecham Group Plc | Préparations vétérinaires pour ruminants |
JPS57139012A (en) * | 1981-02-23 | 1982-08-27 | Sankyo Co Ltd | Anthelmintic composition |
US4427663A (en) * | 1982-03-16 | 1984-01-24 | Merck & Co., Inc. | 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof |
US4633372A (en) | 1985-08-26 | 1986-12-30 | The Standard Oil Company | Polyoxometalate-modified carbon electrodes and uses therefor in capacitors |
EP0237482A1 (fr) * | 1986-03-06 | 1987-09-16 | Ciba-Geigy Ag | Dérivés de la C(29)-carbonyloxy-milbémycine pour la lutte contre les parasites d'espèces végétales ou animales |
BR8701302A (pt) * | 1986-03-25 | 1987-12-22 | Sankyo Co | Compostos macrolideos,sua preparacao e seu uso |
EP0252879B1 (fr) * | 1986-07-02 | 1992-05-06 | Ciba-Geigy Ag | Pesticides |
US4855317A (en) * | 1987-03-06 | 1989-08-08 | Ciba-Geigy Corporation | Insecticides and parasiticides |
US4871719A (en) * | 1987-03-24 | 1989-10-03 | Ciba-Geigy Corporation | Composition for controlling parasites in productive livestock |
US4874749A (en) * | 1987-07-31 | 1989-10-17 | Merck & Co., Inc. | 4"-Deoxy-4-N-methylamino avermectin Bla/Blb |
EP0319142B1 (fr) * | 1987-11-03 | 1994-04-06 | Beecham Group Plc | Intermédiaires pour la preparation des antibiotiques macrolides à activité anthelmintique |
NZ232422A (en) * | 1989-02-16 | 1992-11-25 | Merck & Co Inc | 13-ketal milbemycin derivatives and parasiticides |
JP2893901B2 (ja) | 1990-09-07 | 1999-05-24 | 株式会社岐阜免疫研究所 | 動物用抗体含有油性ペースト製剤 |
JP3182229B2 (ja) | 1992-09-17 | 2001-07-03 | 大日本製薬株式会社 | 動物用懸濁型ペースト剤 |
US5345377A (en) | 1992-10-30 | 1994-09-06 | Electric Power Research Institute, Inc. | Harmonic controller for an active power line conditioner |
IL108366A (en) * | 1993-03-11 | 1999-11-30 | Taro Vit Ind Ltd | Semi-solid pharmaceutical compounds and a device for their use |
AUPM969994A0 (en) * | 1994-11-28 | 1994-12-22 | Virbac S.A. | Equine anthelmintic formulations |
DE19520275A1 (de) | 1995-06-02 | 1996-12-05 | Bayer Ag | Endoparasitizide Mittel |
US6165987A (en) * | 1996-07-30 | 2000-12-26 | Harvey; Colin Manson | Anthelmintic formulations |
IL126741A0 (en) | 1998-10-25 | 1999-08-17 | Yam Daniel | Solidification of fluid oils and their use |
NZ336832A (en) | 1999-07-21 | 2000-10-27 | Ancare New Zealand Ltd | Anthelmintic formulation comprising praziquantel, a macrolide, a preservative, buffer salts, defoaming agent, dispersing agent and water |
US6787342B2 (en) | 2000-02-16 | 2004-09-07 | Merial Limited | Paste formulations |
US6340672B1 (en) * | 2000-02-16 | 2002-01-22 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
US6207179B1 (en) * | 2000-05-18 | 2001-03-27 | Phoenix Scientific, Inc. | Parasiticidal formulation for animals and a method of making this formulation |
US7001889B2 (en) * | 2002-06-21 | 2006-02-21 | Merial Limited | Anthelmintic oral homogeneous veterinary pastes |
-
2002
- 2002-06-21 US US10/177,822 patent/US7001889B2/en not_active Expired - Lifetime
-
2003
- 2003-06-13 NZ NZ555185A patent/NZ555185A/en not_active IP Right Cessation
- 2003-06-13 CA CA2490309A patent/CA2490309C/fr not_active Expired - Lifetime
- 2003-06-13 MX MXPA05000172A patent/MXPA05000172A/es active IP Right Grant
- 2003-06-13 SI SI200331229T patent/SI1534072T1/sl unknown
- 2003-06-13 DE DE60319996T patent/DE60319996T2/de not_active Expired - Lifetime
- 2003-06-13 DK DK03737140T patent/DK1534072T3/da active
- 2003-06-13 WO PCT/US2003/019025 patent/WO2004000034A2/fr active Application Filing
- 2003-06-13 AT AT03737140T patent/ATE390123T1/de active
- 2003-06-13 PT PT03737140T patent/PT1534072E/pt unknown
- 2003-06-13 JP JP2004515836A patent/JP4342440B2/ja not_active Expired - Lifetime
- 2003-06-13 NZ NZ537407A patent/NZ537407A/en not_active IP Right Cessation
- 2003-06-13 ES ES03737140T patent/ES2306879T3/es not_active Expired - Lifetime
- 2003-06-13 BR BR0312141-0A patent/BR0312141A/pt not_active Application Discontinuation
- 2003-06-13 EP EP03737140A patent/EP1534072B1/fr not_active Expired - Lifetime
- 2003-06-20 AR ARP030102207A patent/AR039722A1/es not_active Application Discontinuation
-
2004
- 2004-12-20 ZA ZA2004/10250A patent/ZA200410250B/en unknown
- 2004-12-21 TN TNP2004000258A patent/TNSN04258A1/en unknown
- 2004-12-30 MA MA28026A patent/MA27313A1/fr unknown
-
2005
- 2005-04-15 US US11/107,048 patent/US7563773B2/en not_active Expired - Lifetime
-
2008
- 2008-06-24 CY CY20081100661T patent/CY1108533T1/el unknown
-
2009
- 2009-01-30 AU AU2009200336A patent/AU2009200336B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA2490309A1 (fr) | 2003-12-31 |
CA2490309C (fr) | 2011-09-27 |
NZ537407A (en) | 2007-07-27 |
US20050176657A1 (en) | 2005-08-11 |
WO2004000034A2 (fr) | 2003-12-31 |
ZA200410250B (en) | 2005-11-30 |
JP2005533806A (ja) | 2005-11-10 |
JP4342440B2 (ja) | 2009-10-14 |
NZ555185A (en) | 2009-04-30 |
BR0312141A (pt) | 2005-06-28 |
US7001889B2 (en) | 2006-02-21 |
SI1534072T1 (sl) | 2008-10-31 |
US20030236203A1 (en) | 2003-12-25 |
DE60319996D1 (de) | 2008-05-08 |
ES2306879T3 (es) | 2008-11-16 |
EP1534072A4 (fr) | 2005-10-26 |
AU2009200336A1 (en) | 2009-02-19 |
DE60319996T2 (de) | 2009-05-20 |
CY1108533T1 (el) | 2014-04-09 |
TNSN04258A1 (en) | 2007-03-12 |
WO2004000034A3 (fr) | 2004-02-26 |
MXPA05000172A (es) | 2005-06-03 |
AU2003238245A1 (en) | 2004-01-06 |
AR039722A1 (es) | 2005-03-09 |
EP1534072B1 (fr) | 2008-03-26 |
ATE390123T1 (de) | 2008-04-15 |
PT1534072E (pt) | 2008-06-03 |
DK1534072T3 (da) | 2008-07-14 |
AU2009200336B2 (en) | 2011-09-15 |
US7563773B2 (en) | 2009-07-21 |
EP1534072A2 (fr) | 2005-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27313A1 (fr) | Pates veterinaires homogenes orales anthelminthiques. | |
MA34655B1 (fr) | Dérivés de 2,3- dihydroimidazo[1,2-c]quinazoléine substitués par un aminoalcool utiles pour traiter des troubles hyperprolifératifs et des maladies associées à l'angiogenèse | |
BR9911596A (pt) | Nucleosìdeos tendo porção açúcar bicìclico | |
HRP20060251A2 (en) | Substituted oxasolidinones and their use | |
MA27156A1 (fr) | NUCLEOSIDES 3- β-D-RIBOFURANOSYLTHIAZOLO[4,5-d] PYRIDIMINE ET LES UTILISATIONS DE CELLES-CI | |
MA26946A1 (fr) | Derives de pyrazole nouveaux et leur utilisation comme inhibiteurs de proteine-kinases. | |
MA27316A1 (fr) | Derives d'indoline-phenylsulfonamide | |
CN101257897A (zh) | 用于治疗或预防肥胖、胰岛素抵抗障碍和线粒体相关障碍的方法和相关组合物 | |
TNSN00065A1 (fr) | Derives nouveaux de pyrimidine inhibiteurs de sorbitol- deshydrogenase, leur procede de preparation et compositions pharmaceutiques les contenant. | |
MA27428A1 (fr) | Derives de pyrimidine et leur utilisation en tant que modulateurs cb2 | |
MA30063B1 (fr) | Derives pyrimidinyl-aryluree constituant des inhibiteurs des facteurs de croissance des fibroblastes (fcg) | |
MA27867A1 (fr) | Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif. | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
MA31319B1 (fr) | Dérivés de sulfonylamides destines au traitement d'une croissance cellulaire anormale | |
MA27305A1 (fr) | Derives de 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene et leur utilisation en tant qu'inhibiteurs de renine dans le traitement de l'hypertension, de maladies cardiovasculaires ou renales | |
ATE237587T1 (de) | 11,15-o-dialkylprostaglandin-e-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese als aktiven inhaltsstoff enthalten | |
MA30073B1 (fr) | Derives de piperidine 3,5-substitues en tant qu'inhibiteurs de renine | |
KR927003615A (ko) | 항바이러스 피리미딘 뉴클레오티드 | |
MA28038A1 (fr) | Thienopyrazoles | |
WO2006070325A3 (fr) | Derives de 2,3,4,9-tetrahydro-1h-carbazole utilises en tant qu'antagonistes des recepteurs de crth2 | |
MA27087A1 (fr) | Compositions pharmaceutiques comprenant le glibenclamide et la metformine destinees au traitement du diabete sucre de type ii | |
TNSN06370A1 (fr) | Derives de pyrimidine pour le traitement d'une croissance cellulaire anormale | |
MA28286A1 (fr) | Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant | |
ATE383345T1 (de) | Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten. | |
WO2004069365A8 (fr) | Agents d'imagerie diagnostiques a activite inhibitrice de mmp |